Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
October-2022 Volume 61 Issue 4

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
October-2022 Volume 61 Issue 4

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data1.pdf
    • Supplementary_Data2.pdf
Article Open Access

LIS1 interacts with CLIP170 to promote tumor growth and metastasis via the Cdc42 signaling pathway in salivary gland adenoid cystic carcinoma

  • Authors:
    • Lijun Li
    • Zhihao Wen
    • Ni Kou
    • Jing Liu
    • Dong Jin
    • Lina Wang
    • Fu Wang
    • Lu Gao
  • View Affiliations / Copyright

    Affiliations: School of Stomatology, Dalian Medical University, Dalian, Liaoning 116044, P.R. China
    Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 129
    |
    Published online on: September 12, 2022
       https://doi.org/10.3892/ijo.2022.5419
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Salivary gland adenoid cystic carcinoma (SACC) is one of the most common malignant tumors, with high aggressive potential in the oral and maxillofacial regions. Lissencephaly 1 (LIS1) is a microtubule‑organizing center‑associated protein that regulates the polymerization and stability of microtubules by mediating the motor function of dynein. Recent studies have suggested that LIS1 plays a potential role in the malignant development of tumors, such as in mitosis and migration. However, the role of LIS1 in SACC development and its related molecular mechanisms remain unclear. Thus, the effects of LIS1 on the proliferation, apoptosis, invasion and metastasis of SACC were studied, in vivo and in vitro. The results of immunohistochemical staining showed that LIS1 was highly expressed in SACC tissues, and its expression level was associated with malignant progression. In vitro, the results of CCK‑8, TUNEL, wound healing and Transwell assays demonstrated that LIS1 promotes proliferation, inhibits apoptosis, and enhances the migration and invasion of SACC‑LM cells. In vivo, knockdown of LIS1 effectively suppressed the growth of subcutaneous tumors in a mouse xenograft and distant metastasis of tumor cells in the metastasis model. The co‑immunoprecipitation, immunofluorescence and western blot results also revealed that LIS1 binds to cytoplasmic linker protein 170 (CLIP170) to form a protein complex (LIS1/CLIP170), which activates the cell division control protein 42 homolog (Cdc42) signaling pathway to modulate the proliferation and anti‑apoptosis of tumor cells, and enhanced invasion and metastasis by regulating the formation of invadopodia and the expression of MMPs in SACC‑LM cells. Therefore, the present study demonstrated that LIS1 is a cancer promoter in SACC, and the molecular mechanism of the LIS1/CLIP170/Cdc42 signaling pathway is involved in the malignant progression, which offers a promising strategy for targeted therapy of SACC.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

View References

1 

Laurie SA, Ho AL, Fury MG, Sherman E and Pfister DG: Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: A systematic review. Lancet Oncol. 12:815–824. 2011. View Article : Google Scholar

2 

Su BH, Qu J, Song M, Huang XY, Hu XM, Xie J, Zhao Y, Ding LC, She L, Chen J, et al: NOTCH1 signaling contributes to cell growth, anti-apoptosis and metastasis in salivary adenoid cystic carcinoma. Oncotarget. 5:6885–6895. 2014. View Article : Google Scholar : PubMed/NCBI

3 

Kong J, Tian H, Zhang F, Zhang Z, Li J, Liu X, Li X, Liu J, Li X, Jin D, et al: Extracellular vesicles of carcinoma-associated fibroblasts creates a pre-metastatic niche in the lung through activating fibroblasts. Mol Cancer. 18:1752019. View Article : Google Scholar : PubMed/NCBI

4 

Al Absi A, Wurzer H, Guerin C, Hoffmann C, Moreau F, Mao X, Brown-Clay J, Petrolli R, Casellas CP, Dieterle M, et al: Actin cytoskeleton remodeling drives breast cancer cell escape from natural killer-mediated cytotoxicity. Cancer Res. 78:5631–5643. 2018. View Article : Google Scholar : PubMed/NCBI

5 

Prahl LS, Bangasser PF, Stopfer LE, Hemmat M, White FM, Rosenfeld SS and Odde DJ: Microtubule-based control of motor-clutch system mechanics in glioma cell migration. Cell Rep. 25:2591–2604.e8. 2018. View Article : Google Scholar : PubMed/NCBI

6 

Sharma P, Alsharif S, Fallatah A and Chung BM: Intermediate filaments as effectors of cancer development and metastasis: A focus on keratins, vimentin, and nestin. Cells. 8:4972019. View Article : Google Scholar :

7 

Jung YS, Wang W, Jun S, Zhang J, Srivastava M, Kim MJ, Lien EM, Shang J, Chen J, McCrea PD, et al: Deregulation of CRAD-controlled cytoskeleton initiates mucinous colorectal cancer via β-catenin. Nat Cell Biol. 20:1303–1314. 2018. View Article : Google Scholar : PubMed/NCBI

8 

Peng JM, Bera R, Chiou CY, Yu MC, Chen TC, Chen CW, Wang TR, Chiang WL, Chai SP, Wei Y, et al: Actin cytoskeleton remodeling drives epithelial-mesenchymal transition for hepatoma invasion and metastasis in mice. Hepatology. 67:2226–2243. 2018. View Article : Google Scholar

9 

DeSantis ME, Cianfrocco MA, Htet ZM, Tran PT, Reck-Peterson SL and Leschziner AE: Lis1 has two opposing modes of regulating cytoplasmic dynein. Cell. 170:1197–1208.e12. 2017. View Article : Google Scholar : PubMed/NCBI

10 

Allanson JE, Ledbetter DH and Dobyns WB: Classical lissencephaly syndromes: Does the face reflect the brain? J Med Genet. 35:920–923. 1998. View Article : Google Scholar : PubMed/NCBI

11 

Lo FY, Chen HT, Cheng HC, Hsu HS and Wang YC: Overexpression of PAFAH1B1 is associated with tumor metastasis and poor survival in non-small cell lung cancer. Lung Cancer. 77:585–592. 2012. View Article : Google Scholar : PubMed/NCBI

12 

Yang R, Chen Y, Tang C, Li H, Wang B, Yan Q, Hu J and Zou S: MicroRNA-144 suppresses cholangiocarcinoma cell proliferation and invasion through targeting platelet activating factor acetylhydrolase isoform 1b. BMC Cancer. 14:9172014. View Article : Google Scholar : PubMed/NCBI

13 

Coquelle FM, Caspi M, Cordelières FP, Dompierre JP, Dujardin DL, Koifman C, Martin P, Hoogenraad CC, Akhmanova A, Galjart N, et al: LIS1, CLIP-170's key to the dynein/dynactin pathway. Mol Cell Biol. 22:3089–3102. 2002. View Article : Google Scholar : PubMed/NCBI

14 

Jakka P, Bhargavi B, Namani S, Murugan S, Splitter G and Radhakrishnan G: Cytoplasmic linker protein CLIP170 negatively regulates TLR4 signaling by targeting the TLR adaptor protein TIRAP. J Immunol. 200:704–714. 2018. View Article : Google Scholar

15 

Sun X, Li D, Yang Y, Ren Y, Li J, Wang Z, Dong B, Liu M and Zhou J: Microtubule-binding protein CLIP-170 is a mediator of paclitaxel sensitivity. J Pathol. 226:666–673. 2012. View Article : Google Scholar

16 

Gao L, Xue B, Xiang B and Liu KJ: Arsenic trioxide disturbs the LIS1/NDEL1/dynein microtubule dynamic complex by disrupting the CLIP170 zinc finger in head and neck cancer. Toxicol Appl Pharmacol. 403:1151582020. View Article : Google Scholar : PubMed/NCBI

17 

Murphy NP, Binti Ahmad Mokhtar AM, Mott HR and Owen D: Molecular subversion of Cdc42 signalling in cancer. Biochem Soc Trans. 49:1425–1442. 2021. View Article : Google Scholar : PubMed/NCBI

18 

Murphy NP, Mott HR and Owen D: Progress in the therapeutic inhibition of Cdc42 signalling. Biochem Soc Trans. 49:1443–1456. 2021. View Article : Google Scholar : PubMed/NCBI

19 

Chernichenko N, Omelchenko T, Deborde S, Bakst RL, He S, Chen CH, Gusain L, Vakiani E, Katabi N, Hall A and Wong RJ: Cdc42 mediates cancer cell chemotaxis in perineural invasion. Mol Cancer Res. 18:913–925. 2020. View Article : Google Scholar : PubMed/NCBI

20 

Yang X, Li H, Liu XS, Deng A and Liu X: Cdc2-mediated phosphorylation of CLIP-170 is essential for its inhibition of centrosome reduplication. J Biol Chem. 284:28775–28782. 2009. View Article : Google Scholar : PubMed/NCBI

21 

Fukata M, Watanabe T, Noritake J, Nakagawa M, Yamaga M, Kuroda S, Matsuura Y, Iwamatsu A, Perez F and Kaibuchi K: Rac1 and Cdc42 capture microtubules through IQGAP1 and CLIP-170. Cell. 109:873–885. 2002. View Article : Google Scholar : PubMed/NCBI

22 

Maldonado MDM and Dharmawardhane S: Targeting Rac and Cdc42 GTPases in cancer. Cancer Res. 78:3101–3111. 2018. View Article : Google Scholar : PubMed/NCBI

23 

Stengel KR and Zheng Y: Essential role of Cdc42 in Ras-induced transformation revealed by gene targeting. PLoS One. 7:e373172012. View Article : Google Scholar : PubMed/NCBI

24 

Bai J, Li L, Kou N, Bai Y, Zhang Y, Lu Y, Gao L and Wang F: Low level laser therapy promotes bone regeneration by coupling angiogenesis and osteogenesis. Stem Cell Res Ther. 12:4322021. View Article : Google Scholar : PubMed/NCBI

25 

Gao L, Zhang W, Zhong WQ, Liu ZJ, Li HM, Yu ZL and Zhao YF: Tumor associated macrophages induce epithelial to mesenchymal transition via the EGFR/ERK1/2 pathway in head and neck squamous cell carcinoma. Oncol Rep. 40:2558–2572. 2018.PubMed/NCBI

26 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar

27 

Zhang Y, Bai Y, Bai J, Li L, Gao L and Wang F: Targeting soluble epoxide hydrolase with TPPU alleviates irradiation-induced hyposalivation in mice via preventing apoptosis and microcirculation disturbance. Adv Ther. 3:20001152020. View Article : Google Scholar

28 

Gao L, Wang FQ, Li HM, Yang JG, Ren JG, He KF, Liu B, Zhang W and Zhao YF: CCL2/EGF positive feedback loop between cancer cells and macrophages promotes cell migration and invasion in head and neck squamous cell carcinoma. Oncotarget. 7:87037–87051. 2016. View Article : Google Scholar : PubMed/NCBI

29 

Li HM, Yang JG, Liu ZJ, Wang WM, Yu ZL, Ren JG, Chen G, Zhang W and Jia J: Blockage of glycolysis by targeting PFKFB3 suppresses tumor growth and metastasis in head and neck squamous cell carcinoma. J Exp Clin Cancer Res. 36:72017. View Article : Google Scholar : PubMed/NCBI

30 

Markus SM, Marzo MG and McKenney RJ: New insights into the mechanism of dynein motor regulation by lissencephaly-1. Elife. 9:e597372020. View Article : Google Scholar : PubMed/NCBI

31 

Chen W, Wang W, Sun X, Xie S, Xu X, Liu M, Yang C, Li M, Zhang W, Liu W, et al: NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90. Cell Death Dis. 11:5342020. View Article : Google Scholar : PubMed/NCBI

32 

Gorshtein G, Grafinger O and Coppolino MG: Targeting SNARE-mediated vesicle transport to block invadopodium-based cancer cell invasion. Front Oncol. 11:6799552021. View Article : Google Scholar : PubMed/NCBI

33 

Seano G and Primo L: Podosomes and invadopodia: Tools to breach vascular basement membrane. Cell Cycle. 14:1370–1374. 2015. View Article : Google Scholar : PubMed/NCBI

34 

Qadir MI, Parveen A and Ali M: Cdc42: Role in cancer management. Chem Biol Drug Des. 86:432–439. 2015. View Article : Google Scholar : PubMed/NCBI

35 

Cao H, Eppinga RD, Razidlo GL, Krueger EW, Chen J, Qiang L and McNiven MA: Stromal fibroblasts facilitate cancer cell invasion by a novel invadopodia-independent matrix degradation process. Oncogene. 35:1099–1110. 2016. View Article : Google Scholar

36 

Reiner O, Sapoznik S and Sapir T: Lissencephaly 1 linking to multiple diseases: Mental retardation, neurodegeneration, schizophrenia, male sterility, and more. Neuromolecular Med. 8:547–565. 2006. View Article : Google Scholar : PubMed/NCBI

37 

Suzuki SO, McKenney RJ, Mawatari SY, Mizuguchi M, Mikami A, Iwaki T, Goldman JE, Canoll P and Vallee RB: Expression patterns of LIS1, dynein and their interaction partners dynactin, NudE, NudEL and NudC in human gliomas suggest roles in invasion and proliferation. Acta Neuropathol. 113:591–599. 2007. View Article : Google Scholar : PubMed/NCBI

38 

Perzin KH, Gullane P and Clairmont AC: Adenoid cystic carcinomas arising in salivary glands: A correlation of histologic features and clinical course. Cancer. 42:265–282. 1978. View Article : Google Scholar : PubMed/NCBI

39 

Yingling J, Youn YH, Darling D, Toyo-Oka K, Pramparo T, Hirotsune S and Wynshaw-Boris A: Neuroepithelial stem cell proliferation requires LIS1 for precise spindle orientation and symmetric division. Cell. 132:474–486. 2008. View Article : Google Scholar : PubMed/NCBI

40 

Moon HM, Youn YH, Pemble H, Yingling J, Wittmann T and Wynshaw-Boris A: LIS1 controls mitosis and mitotic spindle organization via the LIS1-NDEL1-dynein complex. Hum Mol Genet. 23:449–466. 2014. View Article : Google Scholar

41 

Brehar FM, Dragomir MP, Petrescu GED and Gorgan RM: Fighting cancer stem cell fate by targeting LIS1 a WD40 repeat protein. Front Oncol. 9:11422019. View Article : Google Scholar : PubMed/NCBI

42 

Brehar FM, Gafencu AV, Trusca VG, Fuior EV, Arsene D, Amaireh M, Giovani A and Gorgan MR: Preferential association of lissencephaly-1 gene expression with CD133+ glioblastoma cells. J Cancer. 8:1284–1291. 2017. View Article : Google Scholar :

43 

Wang XY, Yu J, Zhang Y, Zhang FY, Liu KJ and Xiang B: Phenylephrine alleviates 131I damage in submandibular gland through promoting endogenous stem cell regeneration via lissencephaly-1 upregulation. Toxicol Appl Pharmacol. 396:1149992020. View Article : Google Scholar

44 

He S, Li P, Zhong Q, Hou L, Yu Z, Huang Z and Chen X, Fang J and Chen X: Clinicopathologic and prognostic factors in adenoid cystic carcinoma of head and neck minor salivary glands: A clinical analysis of 130 cases. Am J Otolaryngol. 38:157–162. 2017. View Article : Google Scholar : PubMed/NCBI

45 

Reiner O, Carrozzo R, Shen Y, Wehnert M, Faustinella F, Dobyns WB, Caskey CT and Ledbetter DH: Isolation of a Miller-Dieker lissencephaly gene containing G protein beta-subunit-like repeats. Nature. 364:717–721. 1993. View Article : Google Scholar : PubMed/NCBI

46 

Kholmanskikh SS, Dobrin JS, Wynshaw-Boris A, Letourneau PC and Ross ME: Disregulated RhoGTPases and actin cytoskeleton contribute to the migration defect in Lis1-deficient neurons. J Neurosci. 23:8673–8681. 2003. View Article : Google Scholar : PubMed/NCBI

47 

Miller LE, Au V, Mokhtari TE, Goss D, Faden DL and Varvares MA: A contemporary review of molecular therapeutic targets for adenoid cystic carcinoma. Cancers (Basel). 14:9922022. View Article : Google Scholar

48 

Biyanee A, Yusenko MV and Klempnauer KH: Src-family protein kinase inhibitors suppress MYB activity in a p300-dependent manner. Cells. 11:11622022. View Article : Google Scholar : PubMed/NCBI

49 

Ramsay NA and Glover BJ: MYB-bHLH-WD40 protein complex and the evolution of cellular diversity. Trends Plant Sci. 10:63–70. 2005. View Article : Google Scholar : PubMed/NCBI

50 

Cao S, Lu X, Wang L, Qian X, Jin G and Ma H: The functional polymorphisms of LIS1 are associated with acute myeloid leukemia risk in a Han Chinese population. Leuk Res. 54:7–11. 2017. View Article : Google Scholar : PubMed/NCBI

51 

Suzuki K and Takahashi K: Regulation of lamellipodia formation and cell invasion by CLIP-170 in invasive human breast cancer cells. Biochem Biophys Res Commun. 368:199–204. 2008. View Article : Google Scholar : PubMed/NCBI

52 

Sipes NS, Feng Y, Guo F, Lee HO, Chou FS, Cheng J, Mulloy J and Zheng Y: Cdc42 regulates extracellular matrix remodeling in three dimensions. J Biol Chem. 286:36469–36477. 2011. View Article : Google Scholar : PubMed/NCBI

53 

Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M, Segall J, Eddy R, Miki H, Takenawa T and Condeelis J: Molecular mechanisms of invadopodium formation: The role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol. 168:441–452. 2005. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li L, Wen Z, Kou N, Liu J, Jin D, Wang L, Wang F and Gao L: LIS1 interacts with CLIP170 to promote tumor growth and metastasis via the Cdc42 signaling pathway in salivary gland adenoid cystic carcinoma. Int J Oncol 61: 129, 2022.
APA
Li, L., Wen, Z., Kou, N., Liu, J., Jin, D., Wang, L. ... Gao, L. (2022). LIS1 interacts with CLIP170 to promote tumor growth and metastasis via the Cdc42 signaling pathway in salivary gland adenoid cystic carcinoma. International Journal of Oncology, 61, 129. https://doi.org/10.3892/ijo.2022.5419
MLA
Li, L., Wen, Z., Kou, N., Liu, J., Jin, D., Wang, L., Wang, F., Gao, L."LIS1 interacts with CLIP170 to promote tumor growth and metastasis via the Cdc42 signaling pathway in salivary gland adenoid cystic carcinoma". International Journal of Oncology 61.4 (2022): 129.
Chicago
Li, L., Wen, Z., Kou, N., Liu, J., Jin, D., Wang, L., Wang, F., Gao, L."LIS1 interacts with CLIP170 to promote tumor growth and metastasis via the Cdc42 signaling pathway in salivary gland adenoid cystic carcinoma". International Journal of Oncology 61, no. 4 (2022): 129. https://doi.org/10.3892/ijo.2022.5419
Copy and paste a formatted citation
x
Spandidos Publications style
Li L, Wen Z, Kou N, Liu J, Jin D, Wang L, Wang F and Gao L: LIS1 interacts with CLIP170 to promote tumor growth and metastasis via the Cdc42 signaling pathway in salivary gland adenoid cystic carcinoma. Int J Oncol 61: 129, 2022.
APA
Li, L., Wen, Z., Kou, N., Liu, J., Jin, D., Wang, L. ... Gao, L. (2022). LIS1 interacts with CLIP170 to promote tumor growth and metastasis via the Cdc42 signaling pathway in salivary gland adenoid cystic carcinoma. International Journal of Oncology, 61, 129. https://doi.org/10.3892/ijo.2022.5419
MLA
Li, L., Wen, Z., Kou, N., Liu, J., Jin, D., Wang, L., Wang, F., Gao, L."LIS1 interacts with CLIP170 to promote tumor growth and metastasis via the Cdc42 signaling pathway in salivary gland adenoid cystic carcinoma". International Journal of Oncology 61.4 (2022): 129.
Chicago
Li, L., Wen, Z., Kou, N., Liu, J., Jin, D., Wang, L., Wang, F., Gao, L."LIS1 interacts with CLIP170 to promote tumor growth and metastasis via the Cdc42 signaling pathway in salivary gland adenoid cystic carcinoma". International Journal of Oncology 61, no. 4 (2022): 129. https://doi.org/10.3892/ijo.2022.5419
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team